Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
Status:
Completed
Trial end date:
2016-04-13
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine if BVS857 is safe, tolerable and increases thigh
muscle thickness in patients with spinal bulbar and muscular atrophy (SBMA).